Skip to content

Comparing two doses of dexamethasone in addition to Levobupivacaine in Supraclavicular Brachial Plexus Block for Upper limb Orthopaedic Surgeries

Comparing Variable Doses Of Dexamethasone As An Adjuvant To Levobupivacaine In Ultrasound Guided Supraclavicular Brachial Plexus Block For Patients Undergoing Orthopaedic Upper Limb Surgeries A Prospective Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082493
Enrollment
58
Registered
2025-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S629- Unspecified fracture of wrist andhand

Interventions

Intervention1: Inj. Dexamethasone: Inj. Levobupivacaine 0.25 % 20 ml + Inj . Dexamethasone 4 mg diluted to 2 ml with NS = 22 ml. Control Intervention1: Inj. Dexamethasone: Inj. Levobupivacaine 0.25 %

Sponsors

OrthoOne Orthopaedic Speciality Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Elective and Emergency Orthopaedic Upper limb surgeries ASA I , II and III

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To assess the duration of analgesia between 4 mg of dexamethasone and 6 mg of dexamethasone added to levobupivacaineTimepoint: 0 hours , 2 hours , 4 hours , 8 hours , 12 hours , 24 hours

Secondary

MeasureTime frame
To assess the time taken for onset of sensory & motor blockTimepoint: 0 mins , 2 mins , 4 mins , 6 mins , 8 mins , 10 mins , 12 mins , 14 mins , 15 mins;To assess the total requirement of rescue analgesia over a period of 24 hours post- operativelyTimepoint: 0 hours - 24 hours;To assess the Intensity of pain , Haemodynamic status of patients over 24 hoursTimepoint: 0 hours to 24 hours

Countries

India

Contacts

Public ContactDR Ashwin Suuraj V

Ortho-One Orthopaedic Speciality Centre

ashwinsuuraj55@gmail.com8754026064

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026